Cue Biopharma, Inc.CUENASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank80
3Y CAGR+0.1%
5Y CAGR+2.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+0.1%/yr
vs +9.4%/yr prior
5Y CAGR
+2.1%/yr
Consistent
Acceleration
-9.3pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.23M | +11.3% |
| 2024 | $14.59M | -12.6% |
| 2023 | $16.68M | +3.2% |
| 2022 | $16.17M | -6.6% |
| 2021 | $17.31M | +18.1% |
| 2020 | $14.65M | +15.0% |
| 2019 | $12.74M | +12.8% |
| 2018 | $11.30M | +160.6% |
| 2017 | $4.33M | +119.9% |
| 2016 | $1.97M | - |